Skip to main content
Livermore
Livermore
ZHEN

Prosight Management, LP

SEC CIK
0001617201
Latest filing
Aug 14, 2026

Holdings in Q1 2022

Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.

Institution overview
Positions
30
−2 vs. Q4 2021
Portfolio value
$142.1M
−$8.14M (−5.4%) vs. Q4 2021
Filed
May 16, 2022
SEC
Holdings of Prosight Management, LP in Q1 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
LKFTLakefront Biotherapeutics NVSPON ADR374,000$23.2M16.3%+28,100+8.1%AddedHistory
PRTAProthena Corp Public Ltd CoSHS566,538$20.7M14.6%+125,538+28.5%AddedHistory
ALBOAlbireo Pharma, Inc.COM480,000$14.3M10.1%−34,082−6.6%ReducedHistory
CRLCharles River Laboratories International, Inc.COM31,500$8.95M6.3%+16,019+103.5%AddedHistory
KALVKalVista Pharmaceuticals, Inc.COM589,270$8.69M6.1%+179,650+43.9%AddedHistory
CUECue Biopharma, Inc.COM1,510,282$7.37M5.2%+681,240+82.2%AddedHistory
ALDXAldeyra Therapeutics, Inc.COM1,400,239$6.22M4.4%+244,939+21.2%AddedHistory
MGTXMeiraGTx Holdings plcCOM380,700$5.27M3.7%+380,700NewHistory
KZRKezar Life Sciences, Inc.COM300,000$4.99M3.5%−60,000−16.7%ReducedHistory
CNVYConvey Health Solutions Holdings, Inc.COM748,134$4.89M3.4%−28,866−3.7%ReducedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM22,704$3.71M2.6%−9,203−28.8%ReducedHistory
AGLagilon health, inc.COM140,000$3.55M2.5%−10,000−6.7%ReducedHistory
STTKShattuck Labs, Inc.COM798,718$3.40M2.4%+538,475+206.9%AddedHistory
RCKTRocket Pharmaceuticals, Inc.COM203,268$3.22M2.3%+74,563+57.9%AddedHistory
QDELQuidelOrtho CorpCOM25,675$2.89M2.0%+25,675NewHistory
EHCEncompass Health CorpCOM39,900$2.84M2.0%−82,287−67.3%ReducedHistory
OSCROscar Health, Inc.CL A237,500$2.37M1.7%−687,500−74.3%ReducedHistory
ACCDAccolade, Inc.COM124,393$2.18M1.5%+74,393+148.8%AddedHistory
SEMSelect Medical Holdings CorpCOM90,788$2.18M1.5%+90,788NewHistory
CRSPCRISPR Therapeutics AGNAMEN AKT34,000$2.13M1.5%+16,636+95.8%AddedHistory
INMDInMode Ltd.SHS50,000$1.85M1.3%+50,000NewHistory
MIRMMirum Pharmaceuticals, Inc.COM73,930$1.63M1.1%+73,930NewHistory
GMEDGlobus Medical IncStock18,000$1.33M0.9%−2,188−10.8%ReducedHistory
SPRYARS Pharmaceuticals, Inc.COM325,365$1.14M0.8%+271,550+504.6%AddedHistory
NEONeogenomics IncCOM NEW63,524$772.0K0.5%+63,524NewHistory
CGTXCognition Therapeutics IncCOM240,080$660.0K0.5%−61,899−20.5%ReducedHistory
PRQRProQR Therapeutics N.V.SHS EURO599,288$542.0K0.4%+242,671+68.0%AddedHistory
SIOXSio Gene Therapies Inc.COMMON670,300$449.0K0.3%−131,880−16.4%ReducedHistory
IOVAIovance Biotherapeutics, Inc.COM20,000$333.0K0.2%−48,800−70.9%ReducedHistory
CBAYCymaBay Therapeutics, Inc.COM93,923$292.0K0.2%−72,852−43.7%ReducedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Prosight Management, LP in Q1 2022
SecurityClassPutsCalls
Galapagos NV36315X901CALL–$12.1M
Organon & Co68622V956PUT$699.0K–

Sold out since Q4 2021 (8)

Positions held at the end of Q4 2021 that are gone from this filing.

Positions of Prosight Management, LP sold out since Q4 2021
SecurityClassShares in Q4 2021Value in Q4 2021% of portfolio in Q4 2021History
ZGNXZogenix, Inc.COM NEW362,909$5.90M3.9%History
ARNAArena Pharmaceuticals IncCOM NEW45,000$4.18M2.8%History
MORFMorphic Holding, Inc.COM72,898$3.45M2.3%History
Panacea Acquisition Corp. IIG6882C106CL A SHS195,855$1.90M1.3%–
MRNAModerna, Inc.Stock3,700$940.0K0.6%History
PRCTPROCEPT BioRobotics CorpCOM20,000$500.0K0.3%History
XCURExicure, Inc.COM2,426,508$490.0K0.3%History
ODTOdonate Therapeutics, Inc.COM298,900$404.0K0.3%History